The Evolution of Assessing Central Nervous System Complications in Human Immunodeficiency Virus: Where Do We Go From Here?

Abstract In this fifth decade of the human immunodeficiency virus (HIV) epidemic, central nervous system (CNS) complications including cognitive impairment and mental health remain a burden for people with HIV (PWH) on antiretroviral therapy. Despite the persistence of these complications, which often co-occur, the underlying pathophysiology remains elusive and consequently treatments remain limited. To continue to grow our understanding of the underlying mechanisms of CNS complications among PWH, there is a need to reexamine our current approaches, which are now more than 2 decades old. At the 2021 National Institutes of Health–sponsored meeting on Biotypes of CNS Complications in PWH, the Neurobehavioral Working Group addressed the following: (1) challenges inherent to determining CNS complications; (2) heterogeneity in CNS complications; and (3) problems and solutions for examining integrated biotypes. The review below provides a summary of the main points presented and discussed by the Neurobehavioral Working Group at the meeting.

[1]  B. Cuthbert,et al.  Revisiting the seven pillars of RDoC , 2022, BMC Medicine.

[2]  R. Gur,et al.  Predictive Validity of a Computerized Battery for Identifying Neurocognitive Impairments Among Children Living with HIV in Botswana , 2022, AIDS and Behavior.

[3]  Rachal R. Hegde,et al.  Effects of Early-Life Adversities on Neuropsychiatric and Executive Functions in HIV-Positive Adults , 2022, Journal of the International Neuropsychological Society.

[4]  B. Brew,et al.  HIV-1 viral blips are associated with repeated and increasingly high levels of cell-associated HIV-1 RNA transcriptional activity , 2021, AIDS.

[5]  G. Weissberger,et al.  Socioeconomic Mobility and Psychological and Cognitive Functioning in a Diverse Sample of Adults With and Without HIV , 2021, Psychosomatic medicine.

[6]  A. Adimora,et al.  Patterns and Predictors of Cognitive Function Among Virally Suppressed Women With HIV , 2021, Frontiers in Neurology.

[7]  John M. Pearson,et al.  Machine learning prediction of neurocognitive impairment among people with HIV using clinical and multimodal magnetic resonance imaging data , 2021, Journal of NeuroVirology.

[8]  R. Hambleton,et al.  International Test Commission guidelines for test adaptation: A criterion checklist. , 2020, Psicothema.

[9]  Gary S Collins,et al.  Machine learning and artificial intelligence research for patient benefit: 20 critical questions on transparency, replicability, ethics, and effectiveness , 2020, BMJ.

[10]  Jessica L. Montoya,et al.  Metabolic Risk Factors as Differential Predictors of Profiles of Neurocognitive Impairment Among Older HIV+ and HIV- Adults: An Observational Study. , 2019, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[11]  C. Fennema-Notestine,et al.  Use of Neuroimaging to Inform Optimal Neurocognitive Criteria for Detecting HIV-Associated Brain Abnormalities , 2019, Journal of the International Neuropsychological Society.

[12]  M. Oliveri.  ITC Guidelines for the Large-Scale Assessment of Linguistically and Culturally Diverse Populations , 2019, International Journal of Testing.

[13]  Linglong Kong,et al.  Machine learning models reveal neurocognitive impairment type and prevalence are associated with distinct variables in HIV/AIDS , 2019, Journal of NeuroVirology.

[14]  I. Grant,et al.  Cognitive trajectory phenotypes in human immunodeficiency virus infected patients , 2019, Journal of acquired immune deficiency syndromes.

[15]  G. Barker,et al.  Clinical and neuroimaging correlates of cognition in HIV , 2019, Journal of NeuroVirology.

[16]  D. Jeste,et al.  Effects of Trauma, Economic Hardship, and Stress on Neurocognition and Everyday Function in HIV , 2019, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[17]  J. Becker,et al.  Neuropsychological phenotypes among men with and without HIV disease in the multicenter AIDS cohort study , 2018, AIDS.

[18]  D. Byrd,et al.  Motor function declines over time in human immunodeficiency virus and is associated with cerebrovascular disease, while HIV-associated neurocognitive disorder remains stable , 2018, Journal of NeuroVirology.

[19]  R. Leech,et al.  Medicalising normality? Using a simulated dataset to assess the performance of different diagnostic criteria of HIV-associated cognitive impairment , 2018, PloS one.

[20]  I. Grant,et al.  Deficient Emotion Processing is Associated with Everyday Functioning Capacity in HIV-associated Neurocognitive Disorder , 2018, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[21]  Robert M. Bilder,et al.  Effects of social adversity and HIV on subcortical shape and neurocognitive function , 2017, Brain Imaging and Behavior.

[22]  L. Haddow,et al.  Multicenter European Prevalence Study of Neurocognitive Impairment and Associated Factors in HIV Positive Patients , 2017, AIDS and Behavior.

[23]  C. Fennema-Notestine,et al.  Changes in cognitive function in women with HIV infection and early life stress , 2017, AIDS care.

[24]  Tilahun Belete,et al.  Prevalence of HIV Associated Neurocognitive Deficit among HIV Positive People in Ethiopia: A Cross Sectional Study at Ayder Referral Hospital , 2017, Ethiopian journal of health sciences.

[25]  R. Heaton,et al.  Use of Western Neuropsychological Test Battery in Detecting HIV-Associated Neurocognitive Disorders (HAND) in Zambia , 2017, AIDS and Behavior.

[26]  R. Paul,et al.  Proceedings from the NIMH symposium on “NeuroAIDS in Africa: neurological and neuropsychiatric complications of HIV” , 2016, Journal of NeuroVirology.

[27]  L. Rubin,et al.  Untangling the Gordian knot of HIV, stress, and cognitive impairment , 2016, Neurobiology of Stress.

[28]  L. Cysique,et al.  The Chronicity of HIV Infection Should Drive the Research Strategy of NeuroHIV Treatment Studies: A Critical Review , 2016, CNS Drugs.

[29]  Ronald A. Cohen,et al.  Facial emotion recognition impairments are associated with brain volume abnormalities in individuals with HIV , 2015, Neuropsychologia.

[30]  P. Reiss,et al.  Multivariate normative comparison, a novel method for more reliably detecting cognitive impairment in HIV infection , 2015, AIDS.

[31]  M. Okano,et al.  Cohort Study , 2020, Definitions.

[32]  S. Kim,et al.  HIV‐associated neurocognitive disorder in HIV‐infected Koreans: the Korean NeuroAIDS Project , 2014, HIV medicine.

[33]  Avi Allalouf,et al.  ITC Guidelines on Quality Control in Scoring, Test Analysis, and Reporting of Test Scores , 2014 .

[34]  L. Owolabi,et al.  Neurocognitive impairment in HIV-1-infected adults in Sub-Saharan Africa: a systematic review and meta-analysis. , 2013, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[35]  S. Porges,et al.  Atypical autonomic regulation, auditory processing, and affect recognition in women with HIV , 2013, Biological Psychology.

[36]  M. Silveri,et al.  Cardiovascular risk factors and carotid intima‐media thickness are associated with lower cognitive performance in HIV‐infected patients , 2013, HIV medicine.

[37]  D. Byrd,et al.  Major Depressive Disorder, Cognitive Symptoms, and Neuropsychological Performance among Ethnically Diverse HIV+ Men and Women , 2013, Journal of the International Neuropsychological Society.

[38]  I. Grant,et al.  Abstracts from the 12th International Symposium on NeuroVirology , 2013, Journal of NeuroVirology.

[39]  Danielle M. Moore,et al.  Facial emotional processing in HIV infection: relation to neurocognitive and neuropsychiatric status. , 2012, Neuropsychology.

[40]  I. Grant,et al.  Defining Neurocognitive Impairment in HIV: Deficit Scores Versus Clinical Ratings , 2012, The Clinical neuropsychologist.

[41]  Bradford Navia,et al.  Effects of HIV and Early Life Stress on Amygdala Morphometry and Neurocognitive Function , 2012, Journal of the International Neuropsychological Society.

[42]  L. Koski,et al.  Computerized testing augments pencil‐and‐paper tasks in measuring HIV‐associated mild cognitive impairment * , 2011, HIV medicine.

[43]  P. Schulz,et al.  Cardiovascular Risk Factors Associated With Lower Baseline Cognitive Performance in HIV-Positive Persons , 2011, Neurology.

[44]  S. Ratcliffe,et al.  Neurobehavioral Effects in HIV-Positive Individuals Receiving Highly Active Antiretroviral Therapy (HAART) in Gaborone, Botswana , 2011, PloS one.

[45]  E. Daar.  Faculty Opinions recommendation of HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. , 2011 .

[46]  Terry L. Jernigan,et al.  HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors , 2010, Journal of NeuroVirology.

[47]  K. Tashima,et al.  Facial emotion recognition impairments in individuals with HIV , 2010, Journal of the International Neuropsychological Society.

[48]  T. Insel,et al.  Wesleyan University From the SelectedWorks of Charles A . Sanislow , Ph . D . 2010 Research Domain Criteria ( RDoC ) : Toward a New Classification Framework for Research on Mental Disorders , 2018 .

[49]  J. Manly,et al.  Increasing Culturally Competent Neuropsychological Services for Ethnic Minority Populations: A Call to Action , 2010, The Clinical neuropsychologist.

[50]  C. Hinkin,et al.  Neurocognitive functioning in HIV-1 infection: effects of cerebrovascular risk factors and age , 2010, The Clinical neuropsychologist.

[51]  R. Heaton,et al.  Title Neuropsychological Assessment of HIV-Infected Populations in International Settings Permalink , 2009 .

[52]  I. Grant,et al.  Variable patterns of neuropsychological performance in HIV-1 infection , 2008, Journal of clinical and experimental neuropsychology.

[53]  Hilde M. Huizenga,et al.  Multivariate normative comparisons , 2007, Neuropsychologia.

[54]  J. Becker,et al.  Updated research nosology for HIV-associated neurocognitive disorders , 2007, Neurology.

[55]  The International Test Commission.  International Guidelines on Computer-Based and Internet-Delivered Testing , 2006 .

[56]  I. Grant,et al.  Interrater Reliability of Clinical Ratings and Neurocognitive Diagnoses in HIV , 2004, Journal of clinical and experimental neuropsychology.

[57]  A. Mocroft,et al.  Changing incidence of central nervous system diseases in the EuroSIDA cohort , 2004, Annals of neurology.

[58]  S. Rourke,et al.  Cognitive complaints, depression, medical symptoms, and their association with neuropsychological functioning in HIV infection: a structural equation model analysis. , 2003, Neuropsychology.

[59]  M. Antoni,et al.  The importance of cognitive self-report in early HIV-1 infection: validation of a cognitive functional status subscale , 2002, AIDS.

[60]  L. Campbell,et al.  Actual versus self-reported cognitive dysfunction in HIV-1 infection: memory-metamemory dissociations. , 1996, Journal of clinical and experimental neuropsychology.

[61]  O. Selnes,et al.  Metacognition in HIV-1 seropositive asymptomatic individuals: self-ratings versus objective neuropsychological performance. Multicenter AIDS Cohort Study (MACS). , 1991, Journal of clinical and experimental neuropsychology.

[62]  D. Richman,et al.  Evidence for early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections. Studies with neuropsychologic testing and magnetic resonance imaging. , 1987, Annals of internal medicine.